GE HealthCare Technologies (GEHC) Expected to Announce Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) will likely be announcing its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect GE HealthCare Technologies to post earnings of $1.20 per share and revenue of $5.35 billion for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping the consensus estimate of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.06 EPS. On average, analysts expect GE HealthCare Technologies to post $4.93 EPS for the current fiscal year and $5.41 EPS for the next fiscal year.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $70.23 on Wednesday. The firm’s 50 day simple moving average is $68.42 and its 200-day simple moving average is $66.76. The firm has a market cap of $31.72 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.04 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. GE HealthCare Technologies’s payout ratio is 3.21%.

Analysts Set New Price Targets

A number of research firms have commented on GEHC. Royal Bank Of Canada reissued an “outperform” rating on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. UBS Group increased their price objective on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Hovde Group began coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They issued a “market perform” rating and a $14.00 target price for the company. Finally, Citigroup cut their price target on shares of GE HealthCare Technologies from $75.00 to $71.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $78.35.

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.